181 related articles for article (PubMed ID: 11689115)
1. High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay.
Sugano K; Hamada H; Machida M; Ushio H
J Biomol Screen; 2001 Jun; 6(3):189-96. PubMed ID: 11689115
[TBL] [Abstract][Full Text] [Related]
2. Optimized conditions of bio-mimetic artificial membrane permeation assay.
Sugano K; Hamada H; Machida M; Ushio H; Saitoh K; Terada K
Int J Pharm; 2001 Oct; 228(1-2):181-8. PubMed ID: 11576780
[TBL] [Abstract][Full Text] [Related]
3. Permeation characteristics of a hydrophilic basic compound across a bio-mimetic artificial membrane.
Sugano K; Nabuchi Y; Machida M; Asoh Y
Int J Pharm; 2004 May; 275(1-2):271-8. PubMed ID: 15081157
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
5. Drug permeability profiling using cell-free permeation tools: Overview and applications.
Berben P; Bauer-Brandl A; Brandl M; Faller B; Flaten GE; Jacobsen AC; Brouwers J; Augustijns P
Eur J Pharm Sci; 2018 Jul; 119():219-233. PubMed ID: 29660464
[TBL] [Abstract][Full Text] [Related]
6. [Drug permeation through synthetic lipid membranes. 11. Various membrane types used in permeation and absorption models].
Fürst W; Neubert R; Richter H; Reppel L
Pharmazie; 1980 Feb; 35(2):120-1. PubMed ID: 7384181
[No Abstract] [Full Text] [Related]
7. A novel design of artificial membrane for improving the PAMPA model.
Chen X; Murawski A; Patel K; Crespi CL; Balimane PV
Pharm Res; 2008 Jul; 25(7):1511-20. PubMed ID: 18185985
[TBL] [Abstract][Full Text] [Related]
8. [Advances in parallel artificial membrane permeability assay and its applications].
Wu YF; Liu H; Ni JM
Yao Xue Xue Bao; 2011 Aug; 46(8):890-5. PubMed ID: 22007511
[TBL] [Abstract][Full Text] [Related]
9. Effects of lipid composition on membrane permeabilization by sticholysin I and II, two cytolysins of the sea anemone Stichodactyla helianthus.
Valcarcel CA; Dalla Serra M; Potrich C; Bernhart I; Tejuca M; Martinez D; Pazos F; Lanio ME; Menestrina G
Biophys J; 2001 Jun; 80(6):2761-74. PubMed ID: 11371451
[TBL] [Abstract][Full Text] [Related]
10. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
Akamatsu M; Fujikawa M; Nakao K; Shimizu R
Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
[TBL] [Abstract][Full Text] [Related]
11. pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling.
Oja M; Maran U
Eur J Pharm Sci; 2018 Oct; 123():429-440. PubMed ID: 30100533
[TBL] [Abstract][Full Text] [Related]
12. The PAMPA technique as a HTS tool for partition coefficients determination in different solvent/water systems.
Ottaviani G; Martel S; Escarala C; Nicolle E; Carrupt PA
Eur J Pharm Sci; 2008 Sep; 35(1-2):68-75. PubMed ID: 18620049
[TBL] [Abstract][Full Text] [Related]
13. A PAMPA study of the permeability-enhancing effect of new ceramide analogues.
Sinkó B; Kökösi J; Avdeef A; Takács-Novák K
Chem Biodivers; 2009 Nov; 6(11):1867-74. PubMed ID: 19937821
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis for lipophilic drug transport through a model lipid membrane with membrane retention.
Lee Y; Choi SQ
Eur J Pharm Sci; 2019 Jun; 134():176-184. PubMed ID: 31022441
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the Passive Intestinal Absorption of Medicinal Plant Extract Constituents with the Parallel Artificial Membrane Permeability Assay (PAMPA).
Petit C; Bujard A; Skalicka-Woźniak K; Cretton S; Houriet J; Christen P; Carrupt PA; Wolfender JL
Planta Med; 2016 Mar; 82(5):424-31. PubMed ID: 26872320
[TBL] [Abstract][Full Text] [Related]
16. [Drug permeation through synthetic lipid membranes. Part 10: The effects of diffusion layers on the permeation process (author's transl)].
Fürst W; Neubert R; Reppel L
Pharmazie; 1980 Feb; 35(2):106-9. PubMed ID: 7384178
[TBL] [Abstract][Full Text] [Related]
17. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
[TBL] [Abstract][Full Text] [Related]
18. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
Hwang KK; Martin NE; Jiang L; Zhu C
J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
[TBL] [Abstract][Full Text] [Related]
19. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
[TBL] [Abstract][Full Text] [Related]
20. [Drug permeation through artificial lipid membranes. 17. The mechanism of ion pair transport].
Neubert R; Fürst W; Böhm W; Dabow S
Pharmazie; 1984 Jun; 39(6):401-3. PubMed ID: 6091156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
